COVID-19 Tragic Pandemic: Concerns over Unintentional “Directed Accelerated Evolution” of Novel Coronavirus (SARS-CoV-2) and Introducing a Modified Treatment Method for ARDS
Author:
Open Access
- 1 April 2020
- journal article
- research article
- Published by Salvia Medical Sciences Ltd in Journal of Biomedical Physics and Engineering
- Vol. 10 (2) , 241-246
Abstract
Global health authorities are trying to work out the current status of the novel coronavirus (COVID-19) outbreak and explore methods to reduce the rate of its transmission to healthy individuals. In this viewpoint we provide insights concerning how health care professionals can unintentionally shift the novel coronavirus type to more drug-resistant forms. It is worth noting that viruses usually have different sensitivities to physical and chemical damaging agents such antiviral drugs, UV and heat ranging from extremely sensitive (ES) to extremely resistant (ER) based on a bell-shaped curve. Given this consideration, the widespread infection of people with such ER viruses would be a real disaster. Here, we introduce a modified treatment method for COVID-19-associated pneumonia. In this proposed method, COVID-19 patients will receive a single dose of 100, 180 or 250 mSv X-ray radiation that is less than the maximum annual radiation dose of the residents of high background radiation areas of Ramsar that is up to 260 mSv. In contrast with antiviral drugs, a single dose of either 100, 180 or 250 mSv of low LET X-rays cannot exert a significant selective pressure on the novel coronavirus (SARS-CoV-2) and hence does not lead to directed accelerated evolution of these viruses. Moreover, Low Dose Radiation (LDR) has the capacity of modulating excessive inflammatory responses, regulating lymphocyte counts, and controling bacterial co-infections in patients with COVID-19.Keywords
This publication has 15 references indexed in Scilit:
- COVID-19: a potential public health problem for homeless populationsThe Lancet Public Health, 2020
- World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)International Journal of Surgery, 2020
- Coronavirus disease 2019: What we know?Journal of Medical Virology, 2020
- [Potential antiviral therapeutics for 2019 Novel Coronavirus].2020
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studiesBioScience Trends, 2020
- Understanding of COVID‐19 based on current evidenceJournal of Medical Virology, 2020
- Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemicAsian Pacific Journal of Allergy and Immunology, 2020
- Modulation of Inflammatory Reactions by Low-Dose Ionizing Radiation: Cytokine Release of Murine Endothelial Cells Is Dependent on Culture ConditionsJournal of Immunology Research, 2018
- Immunomodulatory Effects of Radiation: What is Next for Cancer Therapy?Future Oncology, 2015
- Low-Dose Ionizing Radiation Induces Direct Activation of Natural Killer Cells and Provides a Novel Approach for Adoptive Cellular ImmunotherapyCancer Biotherapy and Radiopharmaceuticals, 2014